Lakshmipriya Nair, Author at Express Pharma

Innovation made in India

India is potentially on track to becoming a $300 billion bioeconomy

Supply chain leadership: Stepping into the spotlight

Trump tariffs on the pharmaceutical sector. A new twist- the US department of commerce initiates a Section 232 investigation

Syngene collaborates with biotech firm to develop bile acid modulator for cholestatic disease treatment

Integrated research campuses: Future of Hyderabad’s life sciences industry

Emcure Pharmaceuticals launches campaign addressing male anaemia

Optimising cloud provisioning for pharmaceutical compliance and operational excellence

UCB and Biogen’s dapirolizumab pegol paves path for systemic lupus erythematosus treatment

Drug Repurposing: Unlocking access to rare solutions